Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy

被引：0
|
作者：
Kotoha Tatekawa
Hiromitsu Iwata
Takatsune Kawaguchi
Satoshi Ishikura
Fumiya Baba
Shinya Otsuka
Akifumi Miyakawa
Maho Iwana
Yuta Shibamoto
机构：
[1] Nagoya City University Hospital,Department of Radiology
[2] Nagoya Proton Therapy Center,Department of Radiation Oncology
[3] Nagoya West Medical Center,Department of Radiation Oncology
[4] Juntendo University,Department of Radiation Oncology
[5] Nagoya West Medical Center,undefined
来源：
Radiation Oncology | / 9卷
关键词：
Squamous Cell Carcinoma; Tumor Volume; Stereotactic Body Radiotherapy; Gross Tumor Volume; Japan Clinical Oncology Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
    Tatekawa, Kotoha
    Iwata, Hiromitsu
    Kawaguchi, Takatsune
    Ishikura, Satoshi
    Baba, Fumiya
    Otsuka, Shinya
    Miyakawa, Akifumi
    Iwana, Maho
    Shibamoto, Yuta
    RADIATION ONCOLOGY, 2014, 9
  • [2] INTENSITY-MODULATED STEREOTACTIC BODY RADIOTHERAPY FOR STAGE I NON-SMALL-CELL LUNG CANCER
    Kim, M.
    Kim, E.
    Min, C.
    Yeo, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S7 - S7
  • [3] Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer
    Nam Vu
    Onishi, Hiroshi
    Saito, Masahide
    Kuriyama, Kengo
    Komiyama, Takafumi
    Marino, Kan
    Araya, Masayuki
    Aoki, Shinichi
    Saito, Ryo
    Nonaka, Hotaka
    Funayama, Satoshi
    Watanabe, Hiroaki
    Sano, Naoki
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (05) : 740 - 746
  • [4] Particle therapy: a suitable alternative to stereotactic body radiotherapy for stage I non-small-cell lung cancer?
    Shibamoto, Yuta
    LUNG CANCER MANAGEMENT, 2013, 2 (05) : 353 - 356
  • [5] Opportunities and limitations of fractionated stereotactic body radiotherapy for stage I/II non-small-cell lung cancer
    Adebahr, Sonja
    Bernhardt, Denise
    ONKOLOGIE, 2022, 28 (12): : 1051 - 1058
  • [6] Outcome of Stereotactic Body Radiotherapy for Patients with Histologically Proven Stage I Non-Small-Cell Lung Cancer
    Ogata, T.
    Kosaka, Y.
    Imagumbai, T.
    Ogura, K.
    Hattori, T.
    Hiraoka, S.
    Kokubo, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E524 - E524
  • [7] FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
    Hoopes, David J.
    Tann, Mark
    Fletcher, James W.
    Forquer, Jeffrey A.
    Lin, Pei-Fen
    Lo, Simon S.
    Timmerman, Robert D.
    McGarry, Ronald C.
    LUNG CANCER, 2007, 56 (02) : 229 - 234
  • [8] Stereotactic body radiotherapy for stage I non-small cell lung cancer
    Martel-Lafay, I.
    ONCOLOGIE, 2012, 14 (05) : 282 - 288
  • [9] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
    Beltramo, G.
    Bergantin, A.
    Martinotti, A.
    Bonfanti, P.
    Bianchi, L. C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571
  • [10] Stereotactic body radiotherapy for stage I non-small cell lung cancer
    Slotman, Ben J.
    JOURNAL OF RADIOSURGERY AND SBRT, 2011, 1 (01): : 63 - 69
12345